A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults

• Status: Completed
• Trial end date: 2008-10-01

Summary

The medications being used in this study are individually approved by the Food and Drug Administration (FDA). The medication under investigation is a combination of two medications in one inhaler. The purpose of this study is to determine how well your asthma is controlled when taking one of the three treatment.

• Phase: Phase 3

Details

• Lead Sponsor: SkyePharma AG
• Collaborators: Abbott; MDS Pharma Services
• Treatments: Fluticasone; Formoterol Fumarate; Xhance